Wednesday, February 10, 2010, 2:39am EST - Canadian Markets open in 6 hours and 51 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Durect Corp. (DRRX)

 On Feb 9: 2.01 USD  Up 0.06 (3.08%)  
MORE ON DRRX
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Durect Corporation (NGM:DRRX) Delayed quote dataEdit
After Hours: 2.01 0.00 (0.00%) as of 4:34pm EST on 02/09/10
Last Trade: 2.01 USD
Trade Time: Feb 9
Change: Up 0.06 (3.08%)
Prev Close: 1.95
Open: 1.99
Bid: 1.93 x 100
Ask: 2.13 x 1000
1y Target Est: 10.08
Day's Range: 1.91 - 2.01
52wk Range: 1.40 - 3.18
Volume: 135,259
Avg Vol (3m): 178,075
Market Cap: 174.36M
P/E (ttm): N/A
EPS (ttm): -0.39
Div & Yield: N/A (N/A%)
Durect Corp. (DRRX)
1d  5d  3m  6m  1y  2y  5y  max 
 Add DRRX to Portfolio   Download Data

HEADLINES
• DURECT CORP Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Thu, Jan 28)
• DURECT CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, Jan 19)
• DURECT Corporation Conference Call to Discuss POSIDUR Phase 3 Program scheduled for 11:00 am ET today
CCBN (Tue, Jan 19)
• DURECT Initiates U.S. Pivotal Phase III POSIDUR(TM) Clinical Trial
PRNewswire (Tue, Jan 19)
• Build Your Fortune With These Winners
at Motley Fool (Wed, Jan 6)
• DURECT CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Thu, Dec 17)
• Durect: Pain anesthesia shows positive results
AP (Thu, Dec 17)
• DURECT Reports Positive Phase IIb Data from POSIDUR(TM) Clinical Program
PRNewswire (Thu, Dec 17)
• DURECT to Present at the 21st Annual Piper Jaffray Health Care Conference
PRNewswire (Mon, Nov 23)
• DURECT CORP Financials
EDGAR Online Financials (Fri, Nov 6)
More Headlines for DRRX...
ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 1.9
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Durect Corporation, a specialty pharmaceutical company, engages in the development of pharmaceutical products based on its proprietary drug delivery technology platforms.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices